-
1
-
-
0025125259
-
Evaluation of the increase in breast cancer incidence in relation to mammography use
-
White E, Lee CY, Kristal AR. Evaluation of the increase in breast cancer incidence in relation to mammography use. J Natl Cancer Inst 1990;82: 1546-52. (Pubitemid 20296504)
-
(1990)
Journal of the National Cancer Institute
, vol.82
, Issue.19
, pp. 1546-1552
-
-
White, E.1
Lee, C.Y.2
Kristal, A.R.3
-
2
-
-
84885187137
-
Nation-wide data on screening performance during the transition to digital mammography: Observations in 6 million screens
-
National Evaluation Team for Breast Cancer Screening in the Netherlands Study Group (NETB)
-
van Luijt PA, Fracheboud J, Heijnsdijk EA, den Heeten GJ, de Koning HJ; National Evaluation Team for Breast Cancer Screening in the Netherlands Study Group (NETB). Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens. Eur J Cancer 2013;49: 3517-25.
-
(2013)
Eur J Cancer
, vol.49
, pp. 3517-3525
-
-
Van Luijt, P.A.1
Fracheboud, J.2
Heijnsdijk, E.A.3
Den Heeten, G.J.4
De Koning, H.J.5
-
3
-
-
0037120975
-
Detection of ductal carcinoma in situ in women undergoing screening mammography
-
Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002;94: 1546-54. (Pubitemid 35277278)
-
(2002)
Journal of the National Cancer Institute
, vol.94
, Issue.20
, pp. 1546-1554
-
-
Ernster, V.L.1
Ballard-Barbash, R.2
Barlow, W.E.3
Zheng, Y.4
Weaver, D.L.5
Cutter, G.6
Yankaskas, B.C.7
Rosenberg, R.8
Carney, P.A.9
Kerlikowske, K.10
Taplin, S.H.11
Urban, N.12
Geller, B.M.13
-
4
-
-
0027383738
-
Positive predictive value of screening mammography by age and family history of breast cancer
-
DOI 10.1001/jama.270.20.2444
-
Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 1993;270: 2444-50. (Pubitemid 23342293)
-
(1993)
Journal of the American Medical Association
, vol.270
, Issue.20
, pp. 2444-2450
-
-
Kerlikowske, K.1
Grady, D.2
Barclay, J.3
Sickles, E.A.4
Eaton, A.5
Ernster, V.6
-
5
-
-
79952200754
-
Epidemiology of ductal carcinoma in situ
-
Kerlikowske K. Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010;2010: 139-41.
-
(2010)
J Natl Cancer Inst Monogr
, vol.2010
, pp. 139-141
-
-
Kerlikowske, K.1
-
6
-
-
0034630285
-
Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program
-
Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med 2000;160: 953-8. (Pubitemid 30191923)
-
(2000)
Archives of Internal Medicine
, vol.160
, Issue.7
, pp. 953-958
-
-
Ernster, V.L.1
Barclay, J.2
Kerlikowske, K.3
Wilkie, H.4
Ballard-Barbash, R.5
-
7
-
-
0031941704
-
Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B- 17
-
Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998;16: 441-52. (Pubitemid 28135585)
-
(1998)
Journal of Clinical Oncology
, vol.16
, Issue.2
, pp. 441-452
-
-
Fisher, B.1
Dignam, J.2
Wolmark, N.3
Mamounas, E.4
Costantino, J.5
Poller, W.6
Fisher, E.R.7
Wickerham, D.L.8
Deutsch, M.9
Margolese, R.10
Dimitrov, N.11
Kavanah, M.12
-
8
-
-
0345099342
-
Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy
-
Kerlikowske K, Molinaro A, Cha I, Ljung BM, Ernster VL, Stewart K, et al. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst 2003;95: 1692-702. (Pubitemid 37509078)
-
(2003)
Journal of the National Cancer Institute
, vol.95
, Issue.22
, pp. 1692-1702
-
-
Kerlikowske, K.1
Molinaro, A.2
Cha, I.3
Ljung, B.-M.4
Ernster, V.L.5
Stewart, K.6
Chew, K.7
Moore II, D.H.8
Waldman, F.9
-
9
-
-
0029121769
-
Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy
-
Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995;76: 1197-200.
-
(1995)
Cancer
, vol.76
, pp. 1197-1200
-
-
Page, D.L.1
Dupont, W.D.2
Rogers, L.W.3
Jensen, R.A.4
Schuyler, P.A.5
-
10
-
-
0028060204
-
Long-term follow-up of in situ carcinoma of the breast
-
Eusebi V, Feudale E, Foschini MP, Micheli A, Conti A, Riva C, et al. Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 1994;11: 223-35. (Pubitemid 24308083)
-
(1994)
Seminars in Diagnostic Pathology
, vol.11
, Issue.3
, pp. 223-235
-
-
Eusebi, V.1
Feudale, E.2
Foschini, M.P.3
Micheli, A.4
Conti, A.5
Riva, C.6
Di Palma, S.7
Rilke, F.8
-
11
-
-
0018093363
-
Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone
-
DOI 10.1001/jama.239.18.1863
-
Betsill WL Jr, Rosen PP, Lieberman PH, Robbins GF. Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. JAMA 1978;239: 1863-7. (Pubitemid 8322874)
-
(1978)
Journal of the American Medical Association
, vol.239
, Issue.18
, pp. 1863-1867
-
-
Betsill Jr., W.L.1
Rosen, P.P.2
Lieberman, P.H.3
Robbins, G.F.4
-
12
-
-
58349088766
-
Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast
-
Lester SC, Bose S, Chen Y-Y, Connolly JL, de Baca ME, Fitzgibbons PL, et al. Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast. Arch Pathol Lab Med 2009;133: 15-25.
-
(2009)
Arch Pathol Lab Med
, vol.133
, pp. 15-25
-
-
Lester, S.C.1
Bose, S.2
Chen, Y.-Y.3
Connolly, J.L.4
De Baca, M.E.5
Fitzgibbons, P.L.6
-
13
-
-
0033178304
-
Pathologic findings from the national surgical adjuvant breast project (NSABP) eight-year update of protocol b-17: Intraductal carcinoma
-
DOI 10.1002/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2- Y
-
Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, Wolmark N. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 1999;86: 429-38. (Pubitemid 29347405)
-
(1999)
Cancer
, vol.86
, Issue.3
, pp. 429-438
-
-
Fisher, E.R.1
Dignam, J.2
Tan-Chiu, E.3
Costantino, J.4
Fisher, B.5
Paik, S.6
Wolmark, N.7
-
14
-
-
0030729519
-
Ductal carcinoma in situ of the breast: Correlation of pathologic and mammographic features with extent of disease
-
Coombs JH, Hubbard E, Hudson K, Wunderlich C, VanMeter S, Bell JL, Gwin JL. Ductal carcinoma in situ of the breast: correlation of pathologic and mammographic features with extent of disease. Am Surg 1997;63: 1079-83. (Pubitemid 27512427)
-
(1997)
American Surgeon
, vol.63
, Issue.12
, pp. 1079-1083
-
-
Coombs, J.H.1
Hubbard, E.2
Hudson, K.3
Wunderlich, C.4
Vanmeter, S.5
Bell, J.L.6
Gwin, J.L.7
-
15
-
-
33646216968
-
Correlation between imaging and pathology in ductal carcinoma in situ of the breast
-
De Roos MA, Pijnappel RM, Post WJ, De VJ, Baas PC, Groote LD. Correlation between imaging and pathology in ductal carcinoma in situ of the breast. World J Surg Oncol 2004;2:4.
-
(2004)
World J Surg Oncol
, vol.2
, pp. 4
-
-
De Roos, M.A.1
Pijnappel, R.M.2
Post, W.J.3
De Vj Baas, P.C.4
Groote, L.D.5
-
16
-
-
84885907754
-
Ductal carcinoma in situ: What the pathologist needs to know and why
-
Bane A. Ductal carcinoma in situ: what the pathologist needs to know and why. Int J Breast Cancer 2013:914053, 2013.
-
(2013)
Int J Breast Cancer
, vol.2013
, pp. 914053
-
-
Bane, A.1
-
17
-
-
0035871577
-
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853
-
Bijker N, Peterse JL, Duchateau L, Julien JP, Fentiman IS, Duval C, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001; 19: 2263-71. (Pubitemid 32366979)
-
(2001)
Journal of Clinical Oncology
, vol.19
, Issue.8
, pp. 2263-2271
-
-
Bijker, N.1
Peterse, J.L.2
Duchateau, L.3
Julien, J.-P.4
Fentiman, I.S.5
Duval, C.6
Di Palma, S.7
Simony-Lafontaine, J.8
De Mascarel, I.9
Van De Vijver, M.J.10
-
18
-
-
0028921807
-
Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators
-
Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators. Cancer 1995;75: 1310-9.
-
(1995)
Cancer
, vol.75
, pp. 1310-1319
-
-
Fisher, E.R.1
Costantino, J.2
Fisher, B.3
Palekar, A.S.4
Redmond, C.5
Mamounas, E.6
-
19
-
-
0035667297
-
Clinical practice guidelines for the care and treatment of breast cancer: The management of ductal carcinoma in situ (summary of the 2001 update)
-
Olivotto I, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: the management of ductal carcinoma in situ (summary of the 2001 update). CMAJ 2001;165: 912-3. (Pubitemid 34028232)
-
(2001)
Canadian Medical Association Journal
, vol.165
, Issue.7
, pp. 912-913
-
-
Olivotto, I.1
Levine, M.2
-
20
-
-
0032501786
-
The steering committee on clinical practice guidelines for the care and treatment of breast cancer. Canadian association of radiation oncologists
-
The management of ductal carcinoma in situ (DCIS).
-
The management of ductal carcinoma in situ (DCIS). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists. CMAJ 1998;158 Suppl 3:S27-34.
-
(1998)
CMAJ
, vol.158
, Issue.SUPPL. 3
-
-
-
21
-
-
84878747022
-
Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ
-
Collins L, Achacoso N, Haque R, Nekhlyudov L, Fletcher S, Quesenberry C, et al. Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ. Breast Cancer Res Treat 2013;139: 453-60.
-
(2013)
Breast Cancer Res Treat
, vol.139
, pp. 453-460
-
-
Collins, L.1
Achacoso, N.2
Haque, R.3
Nekhlyudov, L.4
Fletcher, S.5
Quesenberry, C.6
-
22
-
-
0142182087
-
The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast
-
DOI 10.1016/S0002-9610(03)00265-4, PII S0002961003002654
-
Silverstein MJ. The University of Southern California/ Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg 2003;186: 337-43. (Pubitemid 38368606)
-
(2003)
American Journal of Surgery
, vol.186
, Issue.4
, pp. 337-343
-
-
Silverstein, M.J.1
-
23
-
-
84873286667
-
Outcomes in patients treated with mastectomy for ductal carcinoma in situ
-
Owen D, Tyldesley S, Alexander C, Speers C, Truong P, Nichol A, Wai ES. Outcomes in patients treated with mastectomy for ductal carcinoma in situ. Int J Radiat Oncol Biol Phys 2013;85:e129-34.
-
(2013)
Int J Radiat Oncol Biol Phys
, vol.85
-
-
Owen, D.1
Tyldesley, S.2
Alexander, C.3
Speers, C.4
Truong, P.5
Nichol, A.6
Wai, E.S.7
-
24
-
-
0028896111
-
Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast
-
Silverstein MJ, Barth A, Poller DN, Gierson ED, Colburn WJ, Waisman JR, Gamagami P. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 1995;31A: 1425-7.
-
(1995)
Eur J Cancer
, vol.31
, pp. 1425-1427
-
-
Silverstein, M.J.1
Barth, A.2
Poller, D.N.3
Gierson, E.D.4
Colburn, W.J.5
Waisman, J.R.6
Gamagami, P.7
-
25
-
-
0029965510
-
Duct carcinoma in situ: Biological implications for clinical practice
-
Lagios MD. Duct carcinoma in situ: biological implications for clinical practice. Semin Oncol 1996;23: 6-11. (Pubitemid 26105765)
-
(1996)
Seminars in Oncology
, vol.23
, Issue.1 SUPPL. 2
, pp. 6-11
-
-
Lagios, M.D.1
-
26
-
-
0037126341
-
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer
-
DOI 10.1056/NEJMoa022152
-
Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347: 1233-41. (Pubitemid 35176242)
-
(2002)
New England Journal of Medicine
, vol.347
, Issue.16
, pp. 1233-1241
-
-
Fisher, B.1
Anderson, S.2
Bryant, J.3
Margolese, R.G.4
Deutsch, M.5
Fisher, E.R.6
Jeong, J.-H.7
Wolmark, N.8
-
27
-
-
0025177024
-
Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ
-
DOI 10.1016/0140-6736(90)90747-S
-
Holland R, Hendriks JH, Vebeek AL, Mravunac M, Schuurmans SJ. Extent, distribution, and mammographic/ histological correlations of breast ductal carcinoma in situ. Lancet 1990;335: 519-22. (Pubitemid 20073065)
-
(1990)
Lancet
, vol.335
, Issue.8688
, pp. 519-522
-
-
Holland, R.1
Hendriks, J.H.C.L.2
Verbeek, A.L.M.3
Mravunac, M.4
Schuurmans Stekhoven, J.H.5
-
28
-
-
0032894772
-
Predicting the likelihood of residual disease in women treated for ductal carcinoma in situ
-
DOI 10.1016/S1072-7515(98)00266-X, PII S107275159800266X
-
Ratanawichitrasin A, Rybicki LA, Steiger E, Grundfest-Broniatowski S, Hermann RE, Crowe JP. Predicting the likelihood of residual disease in women treated for ductal carcinoma in situ. J Am Coll Surg 1999;188: 17-21. (Pubitemid 29031965)
-
(1999)
Journal of the American College of Surgeons
, vol.188
, Issue.1
, pp. 17-21
-
-
Ratanawichitrasin, A.1
Rybicki, L.A.2
Steiger, E.3
Grundfest-Broniatowski, S.4
Hermann, R.E.5
Crowe, J.P.6
-
29
-
-
34548319130
-
Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: A meta-analysis of randomized trials
-
Viani GA, Stefano EJ, Afonso SL, De Fendi LI, Soares FV, Leon PG, Guimaraes FS. Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials. Radiat Oncol 2007;2:28.
-
(2007)
Radiat Oncol
, vol.2
, pp. 28
-
-
Viani, G.A.1
Stefano, E.J.2
Afonso, S.L.3
De Fendi, L.I.4
Soares, F.V.5
Leon, P.G.6
Guimaraes, F.S.7
-
31
-
-
78650717087
-
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast
-
Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010;2010: 162-77.
-
(2010)
J Natl Cancer Inst Monogr
, vol.2010
, pp. 162-177
-
-
Correa, C.1
McGale, P.2
Taylor, C.3
Wang, Y.4
Clarke, M.5
Davies, C.6
-
32
-
-
34547449160
-
Is sentinel node biopsy necessary in conservatively treated DCIS?
-
DOI 10.1245/s10434-007-9353-4
-
Julian TB, Land SR, Fourchotte V, Haile SR, Fisher ER, Mamounas EP, et al. Is sentinel node biopsy necessary in conservatively treated DCIS? Ann Surg Oncol 2007;14: 2202-8. (Pubitemid 47174907)
-
(2007)
Annals of Surgical Oncology
, vol.14
, Issue.8
, pp. 2202-2208
-
-
Julian, T.B.1
Land, S.R.2
Fourchotte, V.3
Haile, S.R.4
Fisher, E.R.5
Mamounas, E.P.6
Costantino, J.P.7
Wolmark, N.8
-
33
-
-
78650700810
-
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: Long-term results from the UK/ANZ DCIS trial
-
Cuzick J, Sestak I, Pinder SE, Ellis IO, Forsyth S, Bundred NJ, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 2011;12: 21-9.
-
(2011)
Lancet Oncol
, vol.12
, pp. 21-29
-
-
Cuzick, J.1
Sestak, I.2
Pinder, S.E.3
Ellis, I.O.4
Forsyth, S.5
Bundred, N.J.6
-
34
-
-
79952845819
-
Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS
-
Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 2011;103: 478-88.
-
(2011)
J Natl Cancer Inst
, vol.103
, pp. 478-488
-
-
Wapnir, I.L.1
Dignam, J.J.2
Fisher, B.3
Mamounas, E.P.4
Anderson, S.J.5
Julian, T.B.6
-
35
-
-
33846490735
-
The management of ductal carcinoma in situ of the breast: A screened population-based analysis
-
DOI 10.1007/s10549-006-9302-0
-
Rakovitch E, Pignol JP, Chartier C, Hanna W, Kahn H, Wong J, et al. The management of ductal carcinoma in situ of the breast: a screened population-based analysis. Breast Cancer Res Treat 2007;101: 335-47. (Pubitemid 46169888)
-
(2007)
Breast Cancer Research and Treatment
, vol.101
, Issue.3
, pp. 335-347
-
-
Rakovitch, E.1
Pignol, J.-P.2
Chartier, C.3
Hanna, W.4
Kahn, H.5
Wong, J.6
Mai, V.7
Paszat, L.8
-
36
-
-
1642345591
-
Trends in the treatment of ductal carcinoma in situ of the breast
-
Baxter NN, Virnig BA, Durham SB, Tuttle TM. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 2004;96: 443-8. (Pubitemid 38443647)
-
(2004)
Journal of the National Cancer Institute
, vol.96
, Issue.6
, pp. 443-448
-
-
Baxter, N.N.1
Virnig, B.A.2
Durham, S.B.3
Tuttle, T.M.4
-
37
-
-
33644889095
-
Ductal carcinoma in situ: Trends in geographic, temporal, and demographic patterns of care and survival
-
DOI 10.1111/j.1075-122X.2006.00182.x
-
Joslyn SA. Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival. Breast J 2006;12: 20-7. (Pubitemid 43381446)
-
(2006)
Breast Journal
, vol.12
, Issue.1
, pp. 20-27
-
-
Joslyn, S.A.1
-
38
-
-
27244448734
-
The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: A population-based analysis
-
DOI 10.1002/cncr.21406
-
Warren JL, Weaver DL, Bocklage T, Key CR, Platz CE, Cronin KA, et al. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis. Cancer 2005; 104: 1840-8. (Pubitemid 41513166)
-
(2005)
Cancer
, vol.104
, Issue.9
, pp. 1840-1848
-
-
Warren, J.L.1
Weaver, D.L.2
Bocklage, T.3
Key, C.R.4
Platz, C.E.5
Cronin, K.A.6
Ballard-Barbash, R.7
Willey, S.C.8
Harlan, L.C.9
-
39
-
-
73949085809
-
Local excision alone without irradiation for ductal carcinoma in situ of the breast: A trial of the Eastern Cooperative Oncology Group
-
Hughes LL, Wang M, Page DL, Gray R, Solin LJ, Davidson NE, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2009;27: 5319-24.
-
(2009)
J Clin Oncol
, vol.27
, pp. 5319-5324
-
-
Hughes, L.L.1
Wang, M.2
Page, D.L.3
Gray, R.4
Solin, L.J.5
Davidson, N.E.6
-
40
-
-
0033551370
-
The influence of margin width on local control of ductal carcinoma in situ of the breast
-
DOI 10.1056/NEJM199905133401902
-
Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Martino S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 1999;340: 1455-61. (Pubitemid 29220544)
-
(1999)
New England Journal of Medicine
, vol.340
, Issue.19
, pp. 1455-1461
-
-
Silverstein, M.J.1
Lagios, M.D.2
Groshen, S.3
Waisman, J.R.4
Lewinsky, B.S.5
Martino, S.6
Gamagami, P.7
Colburn, W.J.8
-
41
-
-
84891529657
-
Low-risk breast ductal carcinoma in situ (DCIS): Results from the Radiation Therapy Oncology Group 9804 phase 3 trial
-
McCormick B, Moughan J, Hudis C, Kuerer H, Rakovitch E, Smith B, et al. Low-risk breast ductal carcinoma in situ (DCIS): results from the Radiation Therapy Oncology Group 9804 phase 3 trial. Int J Radiat Oncol Biol Phys 2012;84:S5.
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.84
-
-
McCormick, B.1
Moughan, J.2
Hudis, C.3
Kuerer, H.4
Rakovitch, E.5
Smith, B.6
-
42
-
-
77952054026
-
Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis
-
Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F, Bennington J, et al. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst 2010;102: 627-37.
-
(2010)
J Natl Cancer Inst
, vol.102
, pp. 627-637
-
-
Kerlikowske, K.1
Molinaro, A.M.2
Gauthier, M.L.3
Berman, H.K.4
Waldman, F.5
Bennington, J.6
-
43
-
-
38049069125
-
Patterns of care analysis among women with ductal carcinoma in situ in North Carolina
-
Jackson LC, Camacho F, Levine EA, Anderson RT, Stewart JH. Patterns of care analysis among women with ductal carcinoma in situ in North Carolina. Am J Surg 2008;195: 164-9.
-
(2008)
Am J Surg
, vol.195
, pp. 164-169
-
-
Jackson, L.C.1
Camacho, F.2
Levine, E.A.3
Anderson, R.T.4
Stewart, J.H.5
-
44
-
-
78651372009
-
Predictors of local recurrence in a population-based cohort of women with ductal carcinoma in situ treated with breast conserving surgery alone
-
Wai ES, Lesperance ML, Alexander CS, Truong PT, Moccia P, Culp M, et al. Predictors of local recurrence in a population-based cohort of women with ductal carcinoma in situ treated with breast conserving surgery alone. Ann Surg Oncol 2011; 18: 119-24.
-
(2011)
Ann Surg Oncol
, vol.18
, pp. 119-124
-
-
Wai, E.S.1
Lesperance, M.L.2
Alexander, C.S.3
Truong, P.T.4
Moccia, P.5
Culp, M.6
-
45
-
-
33746811910
-
Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of european organisation for research and treatment of cancer randomized phase III trial 10853 - A study by the EORTC breast cancer cooperative group and EORTC radiotherapy group
-
DOI 10.1200/JCO.2006.06.1366
-
Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van H, I, Julien JP, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinomain- situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 2006;24: 3381-7. (Pubitemid 46638893)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.21
, pp. 3381-3387
-
-
Bijker, N.1
Meijnen, P.2
Peterse, J.L.3
Bogaerts, J.4
Van Hoorebeeck, I.5
Julien, J.-P.6
Gennaro, M.7
Rouanet, P.8
Avril, A.9
Fentiman, I.S.10
Bartelink, H.11
Rutgers, E.J.Th.12
-
46
-
-
84879413438
-
Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis
-
Rakovitch E, Nofech-Mozes S, Narod SA, Hanna W, Thiruchelvam D, Saskin R, et al. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis. Breast Cancer Res Treat 2013;138: 581-90.
-
(2013)
Breast Cancer Res Treat
, vol.138
, pp. 581-590
-
-
Rakovitch, E.1
Nofech-Mozes, S.2
Narod, S.A.3
Hanna, W.4
Thiruchelvam, D.5
Saskin, R.6
-
47
-
-
40349103608
-
International Web-based consultation on priorities for translational breast cancer research
-
Dowsett M, Goldhirsch A, Hayes DF, Senn HJ, Wood W, Viale G. International Web-based consultation on priorities for translational breast cancer research. Breast Cancer Res 2007;9:R81.
-
(2007)
Breast Cancer Res
, vol.9
-
-
Dowsett, M.1
Goldhirsch, A.2
Hayes, D.F.3
Senn, H.J.4
Wood, W.5
Viale, G.6
-
48
-
-
70350710119
-
Rethinking screening for breast cancer and prostate cancer
-
Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA 2009;302: 1685-92.
-
(2009)
JAMA
, vol.302
, pp. 1685-1692
-
-
Esserman, L.1
Shieh, Y.2
Thompson, I.3
-
49
-
-
79952284127
-
Hallmarks of cancer: The next generation
-
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144: 646-74.
-
(2011)
Cell
, vol.144
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
50
-
-
0008376153
-
Smoking and carcinoma of the lung; Preliminary report
-
Doll R, Hill AB. Smoking and carcinoma of the lung; preliminary report. Br Med J 1950;2: 739-48.
-
(1950)
Br Med J
, vol.2
, pp. 739-748
-
-
Doll, R.1
Hill, A.B.2
-
51
-
-
34248678430
-
Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis
-
DOI 10.1016/j.molonc.2007.01.004, PII S1574789107000105
-
Herceg Z, Hainaut P. Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis. Mol Oncol 2007;1: 26-41. (Pubitemid 46776619)
-
(2007)
Molecular Oncology
, vol.1
, Issue.1
, pp. 26-41
-
-
Herceg, Z.1
Hainaut, P.2
-
52
-
-
84867232961
-
Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breast
-
Liao S, Desouki MM, Gaile DP, Shepherd L, Nowak NJ, Conroy J, et al. Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breast. Genes Chromosomes Cancer 2012;51: 1067-78.
-
(2012)
Genes Chromosomes Cancer
, vol.51
, pp. 1067-1078
-
-
Liao, S.1
Desouki, M.M.2
Gaile, D.P.3
Shepherd, L.4
Nowak, N.J.5
Conroy, J.6
-
53
-
-
51649118175
-
Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: A calibrated aCGH study
-
Iakovlev VV, Arneson NCR, Wong V, Wang C, Leung S, Iakovleva G, et al. Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study. Clin Cancer Res 2008; 14: 4446-54.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 4446-4454
-
-
Iakovlev, V.V.1
Arneson, N.C.R.2
Wong, V.3
Wang, C.4
Leung, S.5
Iakovleva, G.6
-
54
-
-
33646253192
-
Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression
-
Yao J, Weremowicz S, Feng B, Gentleman RC, Marks JR, Gelman R, et al. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res 2006;66: 4065-78.
-
(2006)
Cancer Res
, vol.66
, pp. 4065-4078
-
-
Yao, J.1
Weremowicz, S.2
Feng, B.3
Gentleman, R.C.4
Marks, J.R.5
Gelman, R.6
-
55
-
-
43049117148
-
The molecular journey from ductal carcinoma in situ to invasive breast cancer
-
DOI 10.1002/cncr.23430
-
Wiechmann L, Kuerer HM. The molecular journey from ductal carcinoma in situ to invasive breast cancer. Cancer 2008;112: 2130-42. (Pubitemid 351628621)
-
(2008)
Cancer
, vol.112
, Issue.10
, pp. 2130-2142
-
-
Wiechmann, L.1
Kuerer, H.M.2
-
56
-
-
84857923923
-
Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence
-
Han K, Nofech-Mozes S, Narod S, Hanna W, Vesprini D, Saskin R, et al. Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence. Clin Oncol (R Coll Radiol) 2012; 24: 183-9.
-
(2012)
Clin Oncol (R Coll Radiol)
, vol.24
, pp. 183-189
-
-
Han, K.1
Nofech-Mozes, S.2
Narod, S.3
Hanna, W.4
Vesprini, D.5
Saskin, R.6
-
57
-
-
84858285120
-
HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ
-
Rakovitch E, Nofech-Mozes S, Hanna W, Narod S, Thiruchelvam D, Saskin R, et al. HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ. Br J Cancer 2012;106: 1160-5.
-
(2012)
Br J Cancer
, vol.106
, pp. 1160-1165
-
-
Rakovitch, E.1
Nofech-Mozes, S.2
Hanna, W.3
Narod, S.4
Thiruchelvam, D.5
Saskin, R.6
-
58
-
-
80053646326
-
Biological markers in DCIS and risk of breast recurrence: A systematic review
-
Lari SA, Kuerer HM. Biological markers in DCIS and risk of breast recurrence: a systematic review. J Cancer 2011;2: 232-61.
-
(2011)
J Cancer
, vol.2
, pp. 232-261
-
-
Lari, S.A.1
Kuerer, H.M.2
-
59
-
-
84870878179
-
Biological markers predictive of invasive recurrence in DCIS
-
Nofech-Mozes S, Spayne J, Rakovitch E, Kahn HJ, Seth A, Pignol JP, et al. Biological markers predictive of invasive recurrence in DCIS. Clin Med Oncol 2008;2: 7-18.
-
(2008)
Clin Med Oncol
, vol.2
, pp. 7-18
-
-
Nofech-Mozes, S.1
Spayne, J.2
Rakovitch, E.3
Kahn, H.J.4
Seth, A.5
Pignol, J.P.6
-
60
-
-
84862489410
-
Is there a low-grade precursor pathway in breast cancer?
-
King TA, Sakr RA, Muhsen S, Andrade VP, Giri D, Van Zee KJ, Morrow M. Is there a low-grade precursor pathway in breast cancer? Ann Surg Oncol 2012;19: 1115-21.
-
(2012)
Ann Surg Oncol
, vol.19
, pp. 1115-1121
-
-
King, T.A.1
Sakr, R.A.2
Muhsen, S.3
Andrade, V.P.4
Giri, D.5
Van Zee, K.J.6
Morrow, M.7
-
61
-
-
21144447899
-
Columnar cell lesions of the breast: The missing link in breast cancer progression? A morphological and molecular analysis
-
DOI 10.1097/01.pas.0000157295.93914.3b
-
Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, et al. Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 2005;29: 734-46. (Pubitemid 40734423)
-
(2005)
American Journal of Surgical Pathology
, vol.29
, Issue.6
, pp. 734-746
-
-
Simpson, P.T.1
Gale, T.2
Reis-Filho, J.S.3
Jones, C.4
Parry, S.5
Sloane, J.P.6
Hanby, A.7
Pinder, S.E.8
Lee, A.H.S.9
Humphreys, S.10
Ellis, I.O.11
Lakhani, S.R.12
-
62
-
-
78650028237
-
The molecular pathology of breast cancer progression
-
Bombonati A, Sgroi DC. The molecular pathology of breast cancer progression. J Pathol 2011;223: 307-17.
-
(2011)
J Pathol
, vol.223
, pp. 307-317
-
-
Bombonati, A.1
Sgroi, D.C.2
-
63
-
-
34447635558
-
Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast
-
Steinman S, Wang J, Bourne P, Yang Q, Tang P. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast. Ann Clin Lab Sci 2007;37: 127-34. (Pubitemid 46717189)
-
(2007)
Annals of Clinical and Laboratory Science
, vol.37
, Issue.2
, pp. 127-134
-
-
Steinman, S.1
Wang, J.2
Bourne, P.3
Yang, Q.4
Tang, P.5
-
64
-
-
84857517254
-
Selecting individualized treatment for patients with ductal carcinoma in situ of the breast: The search continues
-
Solin LJ. Selecting individualized treatment for patients with ductal carcinoma in situ of the breast: the search continues. J Clin Oncol 2012; 30: 577-9.
-
(2012)
J Clin Oncol
, vol.30
, pp. 577-579
-
-
Solin, L.J.1
-
65
-
-
0242380840
-
Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast
-
DOI 10.1016/S0959-8049(02)00666-4, PII S0959804902006664
-
Provenzano E, Hopper JL, Giles GG, Marr G, Venter DJ, Armes JE. Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast. Eur J Cancer 2003;39: 622-30. (Pubitemid 36287374)
-
(2003)
European Journal of Cancer
, vol.39
, Issue.5
, pp. 622-630
-
-
Provenzano, E.1
Hopper, J.L.2
Giles, G.G.3
Marr, G.4
Venter, D.J.5
Armes, J.E.6
-
66
-
-
33745044215
-
The receptor expression pattern in ductal carcinoma in situ predicts recurrence
-
DOI 10.1016/j.amjsurg.2006.04.002, PII S0002961006002418
-
Kepple J, Henry-Tillman RS, Klimberg VS, Layeeque R, Siegel E, Westbrook K, Korourian S. The receptor expression pattern in ductal carcinoma in situ predicts recur-rence. Am J Surg 2006;192: 68-71. (Pubitemid 43870050)
-
(2006)
American Journal of Surgery
, vol.192
, Issue.1
, pp. 68-71
-
-
Kepple, J.1
Henry-Tillman, R.S.2
Klimberg, V.S.3
Layeeque, R.4
Siegel, E.5
Westbrook, K.6
Korourian, S.7
-
67
-
-
80051513712
-
Prognostic markers and long-term outcomes in ductal carcinoma in situ of the breast treated with excision alone
-
Holmes P, Lloyd J, Chervoneva I, Pequinot E, Cornfield DB, Schwartz GF, et al. Prognostic markers and long-term outcomes in ductal carcinoma in situ of the breast treated with excision alone. Cancer 2011;117: 3650-7.
-
(2011)
Cancer
, vol.117
, pp. 3650-3657
-
-
Holmes, P.1
Lloyd, J.2
Chervoneva, I.3
Pequinot, E.4
Cornfield, D.B.5
Schwartz, G.F.6
-
68
-
-
0034892084
-
Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics
-
DOI 10.1016/S0959-8049(01)00165-4, PII S0959804901001654
-
Ringberg A, Anagnostaki L, Anderson H, Idvall I, Ferno M. Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics. European Journal of Cancer 2001; 37: 1514-22. (Pubitemid 32744682)
-
(2001)
European Journal of Cancer
, vol.37
, Issue.12
, pp. 1514-1522
-
-
Ringberg, A.1
Anagnostaki, L.2
Anderson, H.3
Idvall, I.4
Ferno, M.5
-
69
-
-
81155133281
-
Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the genomic health recurrence score in early breast cancer
-
Cuzick J, Dowsett M, Pineda S, Wale C, Salter J, Quinn E, et al. Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the genomic health recurrence score in early breast cancer. J Clin Oncol 2011;29: 4273-8.
-
(2011)
J Clin Oncol
, vol.29
, pp. 4273-4278
-
-
Cuzick, J.1
Dowsett, M.2
Pineda, S.3
Wale, C.4
Salter, J.5
Quinn, E.6
-
70
-
-
84891784645
-
The TEAM trial pathology study identifies potential prognostic and predictive biomarker models for postmenopausal patients treated with endocrine therapy
-
Bartlett JMS, Brookes C, Robson T, van de Velde CH, Billingham LJ, Campbell FM, et al. The TEAM trial pathology study identifies potential prognostic and predictive biomarker models for postmenopausal patients treated with endocrine therapy. Cancer Res 2009;69:503S.
-
(2009)
Cancer Res
, vol.69
-
-
Bartlett, J.M.S.1
Brookes, C.2
Robson, T.3
Van De Velde, C.H.4
Billingham, L.J.5
Campbell, F.M.6
-
71
-
-
33746772725
-
SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast
-
Emdin SO, Granstrand B, Ringberg A, Sandelin K, Arnesson LG, Nordgren H, et al. SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol 2006;45: 536-43.
-
(2006)
Results of A Randomised Trial in A Population Offered Mammography Screening. Acta Oncol
, vol.45
, pp. 536-543
-
-
Emdin, S.O.1
Granstrand, B.2
Ringberg, A.3
Sandelin, K.4
Arnesson, L.G.5
Nordgren, H.6
|